ABL BIOTEC A/S: Financial statements 2014
CVR: 50811018
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -100,370 and a net result of DKK 3,774,071 compared with DKK 2,724,804 the year before. Equity in the 2014 report amounted to DKK 23,712,322. The solvency ratio was 99.3%.
- Gross Profit
- DKK -100,370
- Profit/Loss
- DKK 3,774,071
- Equity
- DKK 23,712,322
- Total Assets
- DKK 23,884,955
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -100K | 3.8M | 23.7M | - |
| 2013 | - | -97K | 2.7M | 22.4M | - |
| 2012 | - | -51K | 3.7M | 21.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ABL BIOTEC A/S has published its annual report for 2013. Gross profit came to DKK -96,915, and the net result was DKK 2,724,804.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.
